Baird lowered the firm’s price target on Thermo Fisher (TMO) to $573 from $603 and keeps an Outperform rating on the shares. The firm updated its model following Q1 results where the company lowered its 2025 revenue and earnings guidance.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher’s Resilience and Strategic Positioning Justify Buy Rating Despite Macroeconomic Challenges
- Thermo Fisher Scientific Reports Strong Q1 2025 Results
- Thermo Fisher Scientific Navigates Strong Q1 Amid Challenges
- Thermo Fisher price target lowered to $610 from $670 at Goldman Sachs
- Thermo Fisher price target lowered to $600 from $625 at Leerink